Fluopyram

ADVERTISEMENT

Identification

Molecular formula
C16H11F3N2O2
CAS Number
658066-35-4
IUPAC Name
2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid
Molecular Weight
396.36g/mol
Melting Point
for a compound of its kind.
Boiling Point
(Celsius)
Density
1.6940g/cm3
Synonyms
niflumic acid
Interesting facts

Interesting Facts about 2-[3-(Trifluoromethyl)anilino]pyridine-3-carboxylic Acid

This compound is a fascinating member of the pyridine derivatives, primarily known for its diverse applications in medicinal chemistry and pharmaceuticals. Here are some intriguing points about this compound:

  • Trifluoromethyl Group: The presence of the trifluoromethyl group in its structure significantly enhances the compound's lipophilicity and biological activity, making it a valuable scaffold in drug design.
  • Pharmacological Potential: Research indicates that compounds like this one may exhibit anticancer, anti-inflammatory, and antiviral properties, which highlights their potential in therapeutic applications.
  • Synthetic Versatility: Its synthesis often involves various methodologies, including nucleophilic substitutions and coupling reactions, which can be adapted for the design of more complex molecules in medicinal chemistry.
  • Binding Profile: The distinct structure allows it to interact with biological targets, aiding the development of selective inhibitors or modulators, particularly in cancer therapy.
  • Research Relevance: Studies on this compound contribute to a broader understanding of structure-activity relationships (SAR) in drug development, providing insights into how molecular modifications impact pharmacological effects.

In summary, 2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid exemplifies the complexity and potential of small molecular compounds in the realm of medicinal chemistry. As science advances, compounds like these often serve as building blocks for innovative treatments and therapies, representing the bridge between basic research and practical application in healthcare.

ADVERTISEMENT